Methylpiperazine

Methylpiperazine

SCHEMBL6016447

CN1CCNCC1.Cc1cc(F)ccc1-c1nc(N2CCN(C)CC2)ncc1C(=O)O

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 3/20 0.46
HSD17B10 Q99714 9/20 0.39
ALDH1A1 P00352 8/20 0.39
CYP1A2 P05177 6/20 0.39
CYP3A4 P08684 6/20 0.39
TSHR P16473 6/20 0.39
USP2 O75604 6/20 0.39
HIF1A Q16665 6/20 0.39
CYP2C9 P11712 4/20 0.39
CASP1 P29466 4/20 0.39
CASP7 P55210 4/20 0.39
GLA P06280 2/20 0.39
MAPK1 P28482 4/20 0.38
ALOX15 P16050 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
MAPT P10636 1/20 0.38
KMT2A Q03164 1/20 0.38
PRKCB P05771 1/20 0.37
PRKCA P17252 1/20 0.37
PRKCH P24723 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4130912 0.94 TACR1 (0.50) TACR1HSD17B10ALDH1A1CYP1A2CYP3A4
SCHEMBL4119980 0.93 ALDH1A1 (0.42) TACR1HSD17B10ALDH1A1CYP1A2CYP3A4
Piperazine SCHEMBL6016696 0.92 ALDH1A1 (0.41) TACR1HSD17B10ALDH1A1CYP1A2CYP3A4
Methylpiperazine SCHEMBL6016589 0.90 TACR1 (0.40) TACR1HSD17B10ALDH1A1CYP1A2CYP3A4
Methylpiperazine SCHEMBL6016369 0.87 TACR1 (0.54) TACR1HSD17B10ALDH1A1CYP1A2CYP3A4
Methylpiperazine SCHEMBL6866949 0.86 TACR1 (0.45) TACR1HSD17B10ALDH1A1CYP1A2CYP3A4
Methylpiperazine SCHEMBL6016623 0.86 ALDH1A1 (0.48) HSD17B10ALDH1A1CYP1A2CYP3A4TSHR
Methylpiperazine SCHEMBL6016376 0.84 TSHR (0.46) TACR1HSD17B10ALDH1A1CYP1A2CYP3A4
SCHEMBL6016413 0.84 TACR1 (0.43) TACR1HSD17B10ALDH1A1CYP1A2CYP3A4
SCHEMBL4124843 0.83 PIK3CA (0.49) HSD17B10ALDH1A1CYP1A2CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1187815-B1 4-PHENYL-PYRIMIDINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2006-02-08 EP disclosed
EP-1187815-A1 4-PHENYL-PYRIMIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2002-03-20 EP disclosed
US-6274588-B1 NEUROKININ OR SUBSTANCE P ANTAGONISTS; CENTRAL NERVOUS SYSTEM AND PSYCHOLOGICAL DISORDES; ANTIDEPRESSANTS, ANXIOLYTIC AGENTS HOFFMANN-LA ROCHE INC. 2001-08-14 US disclosed
WO-2000073279-A1 4-PHENYL-PYRIMIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2000-12-07 WO disclosed